Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients

Author: Tsuge Masataka   Murakami Eisuke   Imamura Michio   Abe Hiromi   Miki Daiki   Hiraga Nobuhiko   Takahashi Shoichi   Ochi Hidenori   Nelson Hayes C.   Ginba Hiroyuki   Matsuyama Kazuhiro   Kawakami Hiroiku   Chayama Kazuaki  

Publisher: Springer Publishing Company

ISSN: 0944-1174

Source: Journal of Gastroenterology, Vol.48, Iss.10, 2013-10, pp. : 1188-1204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content